approved

Dupixent® (dupilumab) Authorized within the U.S. because the First Biologic Drugs for Younger Youngsters with Uncontrolled Persistent Spontaneous Urticaria (CSU)
Partnerships

Dupixent® (dupilumab) Authorized within the U.S. because the First Biologic Drugs for Younger Youngsters with Uncontrolled Persistent Spontaneous Urticaria (CSU)

EURneffy 1 mg permitted throughout the EU as the primary and solely needle-free adrenaline therapy for younger kids (≥15 kg) susceptible to anaphylaxis
Product / Services

EURneffy 1 mg permitted throughout the EU as the primary and solely needle-free adrenaline therapy for younger kids (≥15 kg) susceptible to anaphylaxis